Precigen (PGEN) Operating Income (2012 - 2026)

Precigen (PGEN) has reported Operating Income for 15 consecutive years, with -$6.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Income rose 73.47% year-over-year to -$6.0 million; the TTM figure through Mar 2026 stood at -$93.9 million (up 29.51% YoY), while the FY2025 annual figure was -$110.5 million, up 18.16% from the prior year.
• Operating Income improved to -$6.0 million in Q1 2026 per PGEN's latest filing, from -$21.7 million in the prior quarter.
• Across five years, Operating Income topped out at -$6.0 million in Q1 2026 and bottomed at -$60.8 million in Q2 2024.
• Historically, Operating Income has averaged -$25.1 million across 5 years, with a median of -$22.6 million in 2025.
• Annual changes were most pronounced in 2024 — Operating Income plunged 188.07% — and 2026, when it soared 73.47%.
• Precigen's Operating Income stood at -$21.8 million in 2022, then sank by 57.01% to -$34.2 million in 2023, then rose by 16.68% to -$28.5 million in 2024, then advanced by 24.02% to -$21.7 million in 2025, then soared by 72.33% to -$6.0 million in 2026.
• Business Quant data shows PGEN's Operating Income at -$6.0 million in Q1 2026, -$21.7 million in Q4 2025, and -$34.5 million in Q3 2025.